Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Bennett

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 1973
Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosineE R Block, A E Jennings, J E Bennett
The Journal of Infectious Diseases|April 1, 1972
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitroR D Diamond, R K Root, J E Bennett
The Journal of Infectious Diseases|March 1, 1985
Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndromeR G Washburn, C U Tuazon, J E Bennett
The Journal of Infectious Diseases|August 1, 1990
Flucytosine interference in creatinine assayJ E Bennett, M H Kroll, R G Washburn
The Journal of the Indiana State Medical Association|March 1, 1980
Initial care of the burned patientL R Kinkead, B K Swartz, J E Bennett
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1997
Modeling of trough plasma bismuth concentrationsJ E Bennett, J C Wakefield, L F Lacey
Antimicrobial Agents and Chemotherapy|October 1, 1986
Bioassay for SF 86-327, a new antifungal agentV L Kan, D K Henderson, J E Bennett
Clinical and Experimental Immunology|September 1, 1986
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitroD K Henderson, V L Kan, J E Bennett
Biochemical Pharmacology|March 1, 1978
Mode of action of 5-fluorocytosineR B Diasio, J E Bennett, C E Myers
Annals of Internal Medicine|June 1, 1971
Chronic mucocutaneous candidiasis: model-building in cellular immunityC H Kirkpatrick, R R Rich, J E Bennett
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|October 1, 1973
Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosineE R Block, A E Jennings, J E Bennett
The Journal of Infectious Diseases|April 1, 1972
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitroR D Diamond, R K Root, J E Bennett
The Journal of Infectious Diseases|March 1, 1985
Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndromeR G Washburn, C U Tuazon, J E Bennett
The Journal of Infectious Diseases|August 1, 1990
Flucytosine interference in creatinine assayJ E Bennett, M H Kroll, R G Washburn
The Journal of the Indiana State Medical Association|March 1, 1980
Initial care of the burned patientL R Kinkead, B K Swartz, J E Bennett
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1997
Modeling of trough plasma bismuth concentrationsJ E Bennett, J C Wakefield, L F Lacey
Antimicrobial Agents and Chemotherapy|October 1, 1986
Bioassay for SF 86-327, a new antifungal agentV L Kan, D K Henderson, J E Bennett
Clinical and Experimental Immunology|September 1, 1986
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitroD K Henderson, V L Kan, J E Bennett
Biochemical Pharmacology|March 1, 1978
Mode of action of 5-fluorocytosineR B Diasio, J E Bennett, C E Myers
Annals of Internal Medicine|June 1, 1971
Chronic mucocutaneous candidiasis: model-building in cellular immunityC H Kirkpatrick, R R Rich, J E Bennett
Pageof 21